These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22154083)

  • 1. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
    Chen J; Jiang Z; Wang B; Wang Y; Hu X
    Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
    Chhipa AS; Patel S
    Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
    Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R
    J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ.
    Li Z; Wang Y; Newton IP; Zhang L; Ji P; Li Z
    Cell Signal; 2015 Jun; 27(6):1237-45. PubMed ID: 25748049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
    Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
    Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
    Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
    Liu J; Wu N; Ma L; Liu M; Liu G; Zhang Y; Lin X
    PLoS One; 2014; 9(3):e91606. PubMed ID: 24626155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells.
    Shimada N; Takasawa R; Tanuma SI
    Arch Biochem Biophys; 2018 Jan; 638():1-7. PubMed ID: 29225125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual roles of PKM2 in cancer metabolism.
    Wu S; Le H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
    Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
    Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKM2, a potential target for regulating cancer.
    Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
    Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action at a distance: allostery and the development of drugs to target cancer cell metabolism.
    DeLaBarre B; Hurov J; Cianchetta G; Murray S; Dang L
    Chem Biol; 2014 Sep; 21(9):1143-61. PubMed ID: 25237859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.